Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.
Total raised: $60M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.05.2025 | - | $60M | - |
Mentions in press and media 3
| Date | Title | Description |
| 29.05.2025 | Salvia BioElectronics: A New Dawn for Migraine Sufferers | In the world of chronic pain, migraines reign supreme. They are not just headaches; they are life-altering storms that can sweep away productivity, joy, and social connections. For millions, the search for relief is a relentless journey. En... |
| 27.05.2025 | Salvia BioElectronics raises $60M to accelerate its migraine therapy launch | Dutch medtech Salvia BioElectronics has closed a $60 million Series B funding round to advance its MySalvia Therapy, a minimally invasive neuromodulation solution aimed at treating chronic migraine. The oversubscribed round was led by Amste... |
| 27.05.2025 | Migraines? This Dutch startup just raised €53 million to transform migraine treatment with its ultra-thin implant | Eindhoven-based Salvia BioElectronics, a clinical-stage medical device company innovating neuromodulation therapy for patients with chronic migraine, today announced the successful completion of their €53 million Series B financing round. T... |